Feathers and feather products, Business services, nec, nec
Patrys
Patrys is a publicly listed company located in South Melbourne, Victoria, specializing in the development of innovative antibody technologies aimed at treating cancer and NETosis-driven inflammatory diseases. Their proprietary deoxymab platform targets DNA processes inside cells, effectively crossing the blood-brain barrier and inhibiting NETosis involvement in various health conditions.
The company is focused on creating both single-agent therapies to address specific cancers and inflammatory conditions, as well as combination therapies alongside other treatments. With a strong commitment to advancing therapeutic solutions, Patrys aims to revolutionize the landscape of cancer and inflammatory disease therapies. Generated from the website